Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Dyne Therapeutics Inc (NASDAQ: DYN) closed the day trading at $13.49 down -1.89% from the previous closing price of $13.75. In other words, the price has decreased by -$1.89 from its previous closing price. On the day, 1.97 million shares were traded. DYN stock price reached its highest trading level at $13.87 during the session, while it also had its lowest trading level at $13.335.
Ratios:
For a better understanding of DYN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.83 and its Current Ratio is at 16.83. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
On June 24, 2025, Bernstein started tracking the stock assigning a Mkt Perform rating and target price of $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 14 ’25 when Cox John bought 100,000 shares for $9.11 per share. The transaction valued at 911,000 led to the insider holds 242,179 shares of the business.
Scalzo Richard William bought 1,330 shares of DYN for $19,619 on Jun 11 ’25. On Jun 11 ’25, another insider, Beskrovnaya Oxana, who serves as the Officer of the company, bought 2,132 shares for $14.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 1919141376 and an Enterprise Value of 1356289792.
Stock Price History:
The Beta on a monthly basis for DYN is 1.12, which has changed by -0.5776456 over the last 52 weeks, in comparison to a change of 0.16844666 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $46.26, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is 28.87%, while the 200-Day Moving Average is calculated to be -8.88%.
Shares Statistics:
Over the past 3-months, DYN traded about 3.04M shares per day on average, while over the past 10 days, DYN traded about 2518410 shares per day. A total of 114.34M shares are outstanding, with a floating share count of 109.63M. Insiders hold about 22.72% of the company’s shares, while institutions hold 71.78% stake in the company. Shares short for DYN as of 1755216000 were 17141207 with a Short Ratio of 5.64, compared to 1752537600 on 15730352. Therefore, it implies a Short% of Shares Outstanding of 17141207 and a Short% of Float of 13.450000000000001.
Earnings Estimates
The current assessment of Dyne Therapeutics Inc (DYN) involves the perspectives of 12.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.85, with high estimates of -$0.64 and low estimates of -$1.2.
Analysts are recommending an EPS of between -$3.21 and -$4.37 for the fiscal current year, implying an average EPS of -$3.67. EPS for the following year is -$3.53, with 14.0 analysts recommending between -$2.81 and -$4.95.
